Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
収録刊行物
-
- Cancer Cell
-
Cancer Cell 39 (3), 346-360.e7, 2021-03
Elsevier BV